Recently, several EZH2-specific inhibitors have been developed, and pharmacologic inhibition of EZH2 by these inhibitors (E7438, UNC1999, GSK126, and EPZ005687) has been shown to exert anti-MM effects48,54,57–60. This evidence concerns the gene EZH2 and Miyoshi myopathy.